Cosmetics Company for Sale in Haridwar, India
| Established | 10-20 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 500 - 600 thousand |
| Run Rate Sales | USD 760 thousand |
| EBITDA Margin | 30 - 40 % |
| Industries | Cosmetics + 1 more |
| Locations | Haridwar |
| Local Time | 6:41 AM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
• Operates across major online marketplaces and direct-to-consumer channels, supported by strong repeat demand in skincare and wellness categories.
• Flagship segment includes ampoule-based treatment products such as hair removal solutions, vitamin C serums, and anti-stretch mark treatments, positioned as high-efficacy, premium offerings.
• Additional portfolio includes daily-use skincare products (serums, creams for acne, pigmentation, scars), driving consistent repeat purchases.
• Expanding presence in nutraceuticals with products like Shilajit, Maca, Ginseng, and performance supplements catering to long-term wellness needs.
• Offers herbal tea and wellness products such as slimming and detox teas, creating affordable, high-frequency purchase categories.
• Built a portfolio of 80–90 active SKUs with capability to scale to 170+ formulations across cosmetic and healthcare segments.
• Achieved strong traction with peak daily sales of ₹2–2.5 lakh and monthly revenues reaching ₹60–75 lakh.
• Revenue streams include marketplace sales, D2C channels, wholesale supply, and private label / third-party manufacturing.
• Operates on a low-cost manufacturing and premium pricing strategy, enabling high-margin product categories.
• Provides private label and bulk manufacturing services for cosmetic and nutraceutical partners, adding B2B revenue.
• Backed by experienced promoters with expertise in pharma manufacturing, formulation, e-commerce scaling, and supply chain management.
• Maintains strong relationships with manufacturers, suppliers, and logistics partners to support scalable operations.
• Operates with required registrations, including DPIIT recognition, GST, trademark, and IEC, following ISO and GMP-aligned processes.
• Positioned for scale through export expansion, institutional partnerships, and digital-first growth strategies.
It also includes high-value intangible assets comprising two established brands with trademark registrations, 80–90 active SKUs (expandable to 170+), proprietary formulations, manufacturing SOPs, and product development know-how, which form the core value of the business.
Additionally, the deal covers established e-commerce assets (marketplace experience, listings, SEO structures, and historical performance data), customer insights and repeat purchase data, a fully functional supplier and vendor network, and certifications including DPIIT recognition, GST, IEC, and GMP-aligned processes.
The business further includes a proven high-margin model, historical sales performance, internal systems, training knowledge, and ongoing AI-based healthcare development concepts, along with complete transition support, vendor introductions, and operational handholding.
It currently has no major outstanding loans or long-term liabilities, with operations historically managed through internal cash flows, supplier credit, and working capital cycles, reflecting a low-risk financial structure.
Operations are temporarily paused due to working capital constraints and the need for structured scaling, and the business is actively seeking investment or strategic partnership to restart, expand production and sales, and build a professional management team.
The company is owned by two active promoters holding equal 50% stakes, both directly involved in operations, product development, and strategic decisions.
The business is open to multiple deal structures, including equity investment, majority stake sale, full acquisition, or joint venture, depending on investor alignment.